Tech Company Financing Transactions
Bambusa Therapeutics Funding Round
Bambusa Therapeutics, based in Boston, raised funding from ATHOS KG, BVF Partners and Dawn Biopharma.
Transaction Overview
Company Name
Announced On
11/17/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to: Advance BBT003 and BBT004 through IND-enabling studies and into early clinical development, maintaining Bambusa's pace of advancement; Broaden the bispecific antibody platform into new I&I indications and deepen the pipeline; Strengthen core development infrastructure to support rapid progression through upcoming clinical and regulatory milestones.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shanshan Xu
Co-Founder
Helmut Jeggle
Browse more venture capital transactions:
Prev: 11/17/2025: PowerLattice venture capital transaction
Next: 11/17/2025: Reelables venture capital transaction
Share this article
Where The Data Comes From
We document tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs